Please login to the form below

Not currently logged in
Email:
Password:

The Editors blog

An inside look at what’s happening within the pharma industry and across the PMGroup from the PMLiVE editorial team

Jeux sans frontières

From regulations to customs, 2018 has some big questions to answer

Pharma and Brexit

Here at PMLiVE we began this year anticipating a year of change for pharma and, sure enough, we end the year knowing where the EMA is headed.

But, despite its impending Amsterdam move, 2017 has provided pharma with more questions than answers when it come to Brexit.

That’s particularly true if we try to guess the future shape of UK-EU pharma regulatory relations and the MHRA’s post-Brexit role.

The MHRA could only tell me it is working closely with the government. “We are clear, as is the government, on our desire to retain a close working partnership in respect of medicines regulation after the UK leaves the EU,” a spokesperson said.

“As part of the exit negotiations the UK will discuss with the EU and Member States how best to continue cooperation in the field of medicines regulation in the best interests of business, citizens and patients in both the UK and the EU.”

So, that’s clear then... perhaps.

At least the first phase of the negotiations will no longer hold up the vital next stage of the process.

But even when phase two kicks off in the new year, there are major questions to be faced about customs arrangements and trade deals, in addition to medicines regulations.

For now all that we can hope for is that these games with our frontiers will be played properly in 2018.

Article by
Dominic Tyer

Director of Editorial, PMGroup

22nd December 2017

From: Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics